Hana Biosciences Announces Second Quarter 2008 Results
11 août 2008 16h05 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 11, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced...
Threshold Pharmaceuticals Reports Second Quarter 2008 Financial Results
07 août 2008 16h00 HE
|
Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., Aug. 7, 2008 (PRIME NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today reported financial results for the second quarter ended June 30, 2008.
The net loss for the...
DelSite Subsidiary Sabila Industrial in Costa Rica Completes ISO 9001:2000 Inspection
04 août 2008 12h31 HE
|
DelSite, Inc.
* Sabila Industrial ISO-Certified for More Than Five Years
* No Significant Incidences of Nonconformance Found
* Continued Dedication to Quality
IRVING, Texas, Aug....
Global Biotechnology Company Licenses WinNonlin AutoPilot
31 juil. 2008 12h18 HE
|
Pharsight Corporation
MOUNTAIN VIEW, Calif., July 31, 2008 (PRIME NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug...
Momenta Pharmaceuticals Announces Results From a Phase 1 Study of M118 Administered as a Subcutaneous Injection
29 juil. 2008 13h45 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., July 29, 2008 (PRIME NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Athersys Added to Russell Microcap Index
02 juil. 2008 08h30 HE
|
Athersys, Inc.
CLEVELAND, July 2, 2008 (PRIME NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced it was added to the Russell Microcap(r) Index when Russell Investments reconstituted its comprehensive family...
DelSite Announces Development of Unique Synthetic Typhoid Vi Polysaccharide Vaccine Candidate
26 juin 2008 08h59 HE
|
DelSite, Inc.
* Safer and More Economical Approach Against a Major Infectious
Disease That Causes 500,000 to 600,000 Deaths Worldwide Per Year
* Chemical Composition Similar to Marketed Typhoid...
Biotage has Received its Largest Order to Date
11 août 2005 07h07 HE
|
Biotage AB
STOCKHOLM, Sweden, Aug. 11, 2005 (PRIMEZONE) -- Biotage has received the company's largest single order to date. It includes 31 instruments and totals approx. 15 MSEK. The customer is one of the...
Fidelity Fund Acquires 5.13 Percent Interest in Crucell
28 juin 2005 02h07 HE
|
Crucell N.V.
LEIDEN, Netherlands, June 28, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that Fidelity's FID Growth Company Fund has acquired a 5.13%...
Astex Achieves Drug Discovery Milestone with Boehringer Ingelheim
14 févr. 2005 02h35 HE
|
Astex Therapeutics
CAMBRIDGE, U.K., Feb. 14, 2005 (PRIMEZONE) -- * Astex, the fragment-based drug discovery and development company, today announced that it has successfully achieved the first milestone in its drug...